NCT03466489

Brief Summary

Infection after total joint arthroplasty can have devastating consequences. Adhesive drapes have been traditionally used at our institution to help reduce the risk of wound contamination and infection by superficial skin flora. Our primary objective is to determine if a cyanoacrylate-based sealant (FloraSeal microbial sealant) is superior to conventional iodine impregnated drapes in prevention of both superficial and deep surgical site infections in total joint arthroplasty (TJA) patients. A prospective, randomized controlled model will be used to answer this question.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 15, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

July 22, 2019

Status Verified

July 1, 2019

Enrollment Period

1.8 years

First QC Date

March 8, 2018

Last Update Submit

July 18, 2019

Conditions

Keywords

total joint arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Appearance of Surgical Site

    The surgical incision will be checked post-operatively for signs of infection or dehiscence.

    90 days from date of surgery

Secondary Outcomes (3)

  • Intra-operative cultures

    Intra-operative - Cannot be clearly defined as it will depend on the duration of the surgical procedure.

  • Post-operative complication - Antibiotic administration

    90 days from date of surgery

  • Post-operative complication - Re-operation

    90 days from date of surgery

Study Arms (2)

Floraseal

EXPERIMENTAL

The surgical site will first be cleaned with isopropyl alcohol. Once the site is dry, alcohol based chlorhexidine gluconate preparatory solution will be applied to the surgical site. Once dry, the FloraSeal surgical preparatory solution will be applied per the manufacturers recommendations. The extremity will be draped in sterile fashion however adhesive drapes over the surgical site itself will not be applied.

Device: Floraseal

Control

NO INTERVENTION

The operative site is first cleaned with isopropyl alcohol. Once the site is dry, alcohol based chlorhexidine gluconate preparatory solution will be applied to the surgical site. The operative site will then be draped in sterile fashion. An iodine impregnated adhesive drape will then be applied to the surgical site.

Interventions

FlorasealDEVICE

FloraSeal is a cyanoacrylate-based sealant used in the prevention of surgical site infections.

Floraseal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 18 years of age
  • Have signed the written informed consent form

You may not qualify if:

  • Patients not fluent in the language of the informed consent form
  • Prisoners
  • Pregnancy
  • Reported to have mental illness or belonging to a vulnerable population
  • History of dermatitis or allergic reaction to cyanoacrylate based materials or iodine
  • Patients undergoing revision total joint arthroplasty secondary to infection
  • Allergy to Iodine.
  • Patients undergoing total joint arthroplasty in the setting of acute trauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami Hospital

Miami, Florida, 33136, United States

Location

Related Publications (7)

  • Prince D, Kohan K, Solanki Z, Mastej J, Prince D, Varughese R, et al. Immobilization and death of bacteria by Flora Seal® microbial sealant. International Journal of Pharmaceutical Science Invention. 2017 Jun;6(6):45-9.

    BACKGROUND
  • Zhang S, Ruiz R. FloraSeal® microbial sealant: a comprehensive solution to skin flora. 2015.

    BACKGROUND
  • Lorenzetti AJ, Wongworawat MD, Jobe CM, Phipatanakul WP. Cyanoacrylate microbial sealant may reduce the prevalence of positive cultures in revision shoulder arthroplasty. Clin Orthop Relat Res. 2013 Oct;471(10):3225-9. doi: 10.1007/s11999-013-2854-5.

    PMID: 23471553BACKGROUND
  • Towfigh S, Cheadle WG, Lowry SF, Malangoni MA, Wilson SE. Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Arch Surg. 2008 Sep;143(9):885-91; discussion 891. doi: 10.1001/archsurg.143.9.885.

    PMID: 18794427BACKGROUND
  • Bailey IS, Karran SE, Toyn K, Brough P, Ranaboldo C, Karran SJ. Community surveillance of complications after hernia surgery. BMJ. 1992 Feb 22;304(6825):469-71. doi: 10.1136/bmj.304.6825.469.

    PMID: 1547415BACKGROUND
  • Webster J, Alghamdi A. Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst Rev. 2015 Apr 22;2015(4):CD006353. doi: 10.1002/14651858.CD006353.pub4.

    PMID: 25901509BACKGROUND
  • Fairclough JA, Johnson D, Mackie I. The prevention of wound contamination by skin organisms by the pre-operative application of an iodophor impregnated plastic adhesive drape. J Int Med Res. 1986;14(2):105-9. doi: 10.1177/030006058601400210.

    PMID: 3699240BACKGROUND

Related Links

MeSH Terms

Conditions

Surgical Wound Infection

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Victor H Hernandez, MD

    University of Miami

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Arthroplasty & Joint Reconstruction

Study Record Dates

First Submitted

March 8, 2018

First Posted

March 15, 2018

Study Start

January 1, 2018

Primary Completion

November 1, 2019

Study Completion

February 1, 2020

Last Updated

July 22, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

The researchers will share aggregate data but no individual's data will be shared. De-identified graphs of the accelerometer or range of motion output recordings from the devices may be used to illustrate the device's application.

Locations